| Medical and Health Sciences | Lifetime | 302 | DE 5 | 99.99 |
| Biological Sciences | Lifetime | 295 | DE 20 | 99.96 |
| Biological Sciences | 2021-2025 | 962 | DE 51 | 98.94 |
| Immunology | Lifetime | 110 | DE 3 | 99.79 |
| Molecular Biology | Lifetime | 592 | DE 38 | 99.71 |
| Nutrition and Dietetics | Lifetime | 92 | DE 4 | 99.50 |
| Oncology | Lifetime | 229 | DE 8 | 99.63 |
| Immunology and Allergy | Lifetime | 30 | DE 8 | 99.48 |
| Cancer Research | Lifetime | 201 | DE 11 | 98.86 |
| Surgery | Lifetime | 906 | DE 40 | 99.14 |
| Clinical Pharmacology | Lifetime | 276 | DE 6 | 98.87 |
| Biochemistry | Lifetime | 180 | DE 18 | 97.50 |
| Neuroscience of Neurology | Lifetime | 537 | DE 54 | 95.47 |
| Hematology | Lifetime | 640 | DE 48 | 94.85 |
| Medical Genetics | Lifetime | 734 | DE 73 | 91.65 |
| Otolaryngology | Lifetime | 421 | DE 16 | 92.32 |
| Internal Medicine | Lifetime | 502 | DE 28 | 84.83 |
| Medical Biochemistry | Lifetime | 667 | DE 33 | 69.74 |
| Immunology | 2021-2025 | 103 | DE 8 | 97.95 |
| Cancer Research | 2021-2025 | 167 | DE 6 | 91.32 |
| Oncology | 2021-2025 | 611 | DE 32 | 90.93 |
| Internal Medicine | 2021-2025 | 155 | DE 8 | 52.40 |
| Cell Adhesion Molecules Research | Lifetime | 7 | DE 1 | 99.94 |
| Chemokine receptors and signaling | Lifetime | 2 | DE 1 | 99.91 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 4 | DE 1 | 99.93 |
| Macrophage Migration Inhibitory Factor | Lifetime | 1 | DE 1 | 99.63 |
| Immune cells in cancer | Lifetime | 24 | DE 2 | 99.81 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 18 | DE 2 | 99.76 |
| Fatty Acid Research and Health | Lifetime | 16 | DE 2 | 99.62 |
| Inflammatory mediators and NSAID effects | Lifetime | 29 | DE 1 | 99.64 |
| MicroRNA in disease regulation | Lifetime | 61 | DE 6 | 99.65 |
| Platelet Disorders and Treatments | Lifetime | 28 | DE 4 | 99.53 |
| Angiogenesis and VEGF in Cancer | Lifetime | 63 | DE 7 | 99.48 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 58 | DE 6 | 99.26 |
| Circular RNAs in diseases | Lifetime | 136 | DE 7 | 98.90 |
| Cancer-related molecular mechanisms research | Lifetime | 360 | DE 17 | 98.75 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 175 | DE 12 | 99.08 |
| Immune Response and Inflammation | Lifetime | 345 | DE 23 | 99.11 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 79 | DE 4 | 97.59 |
| Nuclear Receptors and Signaling | Lifetime | 65 | DE 4 | 98.84 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 167 | DE 9 | 98.56 |
| Amoebic Infections and Treatments | Lifetime | 81 | DE 4 | 97.86 |
| Extracellular vesicles in disease | Lifetime | 258 | DE 13 | 97.61 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 303 | DE 18 | 98.54 |
| Cholesterol and Lipid Metabolism | Lifetime | 185 | DE 6 | 97.86 |
| Protease and Inhibitor Mechanisms | Lifetime | 433 | DE 30 | 97.32 |
| Ear Surgery and Otitis Media | Lifetime | 237 | DE 16 | 97.62 |
| Cardiac Fibrosis and Remodeling | Lifetime | 217 | DE 28 | 96.81 |
| Nitric Oxide and Endothelin Effects | Lifetime | 794 | DE 86 | 97.15 |
| Mesenchymal stem cell research | Lifetime | 829 | DE 40 | 96.46 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 876 | DE 67 | 95.90 |
| Vitamin K Research Studies | Lifetime | 185 | DE 8 | 94.43 |
| NF-κB Signaling Pathways | Lifetime | 635 | DE 62 | 94.82 |
| Phagocytosis and Immune Regulation | Lifetime | 405 | DE 36 | 94.04 |
| Cell death mechanisms and regulation | Lifetime | 820 | DE 70 | 94.86 |
| Congenital heart defects research | Lifetime | 829 | DE 60 | 94.60 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 762 | DE 39 | 95.35 |
| Vestibular and auditory disorders | Lifetime | 975 | DE 81 | 94.57 |
| Apelin-related biomedical research | Lifetime | 342 | DE 19 | 91.80 |
| Ear and Head Tumors | Lifetime | 747 | DE 35 | 93.63 |
| Lymphatic System and Diseases | Lifetime | 722 | DE 40 | 88.81 |
| Chemokine receptors and signaling | 2021-2025 | 1 | DE 1 | 99.22 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 5 | DE 1 | 99.38 |
| MicroRNA in disease regulation | 2021-2025 | 159 | DE 4 | 97.71 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 8 | DE 3 | 93.71 |
| Cancer-related molecular mechanisms research | 2021-2025 | 717 | DE 11 | 94.69 |
| Immune cells in cancer | 2021-2025 | 599 | DE 26 | 91.05 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 213 | DE 14 | 89.88 |
| Cell Adhesion Molecules Research | 2021-2025 | 306 | DE 35 | 82.70 |
| Circular RNAs in diseases | 2021-2025 | 993 | DE 11 | 85.16 |
| Neuropeptides and Animal Physiology | 2021-2025 | 324 | DE 21 | 83.36 |
| Receptor Mechanisms and Signaling | 2021-2025 | 808 | DE 63 | 80.96 |
| Platelet Disorders and Treatments | 2021-2025 | 940 | DE 73 | 78.99 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 969 | DE 83 | 53.42 |
| Nuclear Receptors and Signaling | 2021-2025 | 925 | DE 50 | 47.63 |